Address
325 Vassar Street
Ste. 2A, Cambridge
MA, 02139
United States
Contact
Kwangmin Son+1617-955-7376
submissions@phast.ai
Website
PhAST Clinic: Point-of-Need AI Diagnostic Platform
PhAST has developed a phenotypic AST approach with TTR <100 min directly from urine specimens
The PhAST Clinic hardware is relatively simple, and thus affordable, while still delivering strong performance that meets or exceeds FDA requirements.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Validation
- Research
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- CARB-X
- FIND
- GARDP
- REPAIR
- OTHER / NA
Infectious disease area:
- UTI
- BSI
- STI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
N.A.
PhAST is an AI diagnostics company developing a computer-vision platform for the rapid detection of pathogens and associated phenotypic-based AST.
The initial exemplar assay is UTIs. Preliminary work has shown that the same approach works on positive blood cultures in 100 min, faster than any other available phenotypic AST approach. Other potential assays include STIs, fungi, and yeast.
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!